Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2015

Oct 28, 2015

1643_dirs_2015-10-28_c6a33fe0-ae06-44b5-950f-8c224640011d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MyoKardia Inc (MYOK)
CIK: 0001552451
Period of Report: 2015-10-28

Reporting Person: Sanofi (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A-1 redeemable convertible preferred stock $0 Common Shares (1814059) Indirect
Series B redeemable convertible preferred stock $0 Common Shares (504840) Indirect

Footnotes

F1: Converts into common stock

F2: Conversion upon Initial Public Offering